A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Clinical trial NCT07088068 · RECRUITING
Trial details
- NCT number
- NCT07088068
- Sponsor
- Sanofi
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-06
- Primary completion
- 2028-06-06
- Enrollment
- 723
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.